Satellos Bioscience Inc. (MSLE)

Satellos Bioscience will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Satellos Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-24.49	-20.4	-11.33
Net Income	-22.03	-20.63	-11.64

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	34.61	51.17	29
Total Debt	-	0	0
Net Cash (Debt)	34.61	51.17	29
Net Cash Growth	-	76.44%	-

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-21.55	-18.25	-8.49
Capital Expenditures	-0.01	-0	-0.01
Free Cash Flow	-21.56	-18.26	-8.5
Free Cash Flow Growth	-	-	-